e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Guiding antibiotic treatment with inflammatory biomarkers in COPD? Another brick in the wall
Philipp Schuetz, Daiana Stolz
Source:
Eur Respir J, 53 (5) 1900562; 10.1183/13993003.00562-2019
Journal Issue:
May
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Philipp Schuetz, Daiana Stolz. Guiding antibiotic treatment with inflammatory biomarkers in COPD? Another brick in the wall. Eur Respir J, 53 (5) 1900562; 10.1183/13993003.00562-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019
Year: 2019
Double edge sword: antibiotics in the prevention and treatment of COPD exacerbation
Source: Annual Congress 2012 - Respiratory infectious diseases Grand Round: an interactive session
Year: 2012
Air pollution and inflammatory airway disease: therapeutic options
Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=262
Year: 2002
Do we need new therapies for noneosinophilic asthma?
Source: Annual Congress 2004 - Noneosinophilic asthma
Year: 2004
What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Airway inflammation in asthma: current and future targets and therapies
Source: Breathe 2010; 6: 245-252
Year: 2010
Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Cleaning agents and chronic lung disease: does the evidence support a link with COPD?
Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health?
Year: 2018
Bronchiectasis in COPD: increased susceptibility of the airways to aggressive agents?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy
Source: Breathe, 15 (4) 296; 10.1183/20734735.0258-2019
Year: 2019
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009
Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies
Year: 2009
Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Is antibiotic treatment during asthma exacerbation necessary ?
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Bacterial resistance induction with prophylactic antibiotics in COPD
Source: International Congress 2014 – COPD markers
Year: 2014
Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients
Source: Eur Respir J 2014; 44: 603-613
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept